12:37 IST
NSE
Other Announcement
Indoco Remedies Other Announcement
Indoco Remedies disclosed an unsolicited Crisil ESG rating of 'Crisil ESG 60'. The company notes it did not engage Crisil for the assessment.
Indoco Remedies Ltd
- Share price
- ₹245.90
- Market cap
- ₹2,270 Cr
- Revenue (annual)
- ₹1,845 Cr
- Net profit (annual)
- ₹-95.14 Cr
- P/E (TTM)
- 403.1×Sector 47.4×
- Promoter holding
- 58.86%+0.00% QoQ
- FII holding
- 1.27%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Merger & Restructuring 6Promoter Buying 5Business Update 4Regulatory Approval 3Other Announcement 3Financial Results 3Earnings Call 2Board Meeting Date 2Annual General Meeting 2Management Change 1Dividend 1Annual Report 1
Time
3 announcements with these filters
15:45 IST
NSE
Other Announcement
Indoco Remedies Other Announcement
Indoco Remedies has filed its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-2026. The report provides disclosures on ESG, operations, and governance.
09:19 IST
BSE
Other Announcement
Indoco Remedies Other Announcement
Indoco Remedies submitted its Annual Secretarial Compliance Report for FY2025-26. The auditor confirmed adherence to SEBI regulations and statutory provisions without any adverse observations.